Brightpath Biotherapeutics Co., Ltd. recognizes that improvement of transparency and accountability of management are highly important for increasing the efficiency of management and maintaining the soundness of management, and we consider that, in order to achieve this transparency and accountability, corporate governance is very important for management.
We have an independent accounting auditors, as it has both a Board of Directors and a Board of Auditors.
The Board of Directors has four members, and meetings are held at least once per month. At these meetings, proposals and suggestions that are important for management are discussed and decided upon in accordance with laws and ordinances, the Articles of Incorporation, and the rules of the Board of Directors. Furthermore, the company auditors, in addition to attending meetings of the Board of Directors, read and assess various important documents, including documents of settlement , contracts, and draft financial statements.
The Board of Auditors has three members, who have not been company employees or executives. One of the members is a full-time auditor.
This company's corporate governance structure is shown schematically below.